Top Markets
#1 Black Phoenix Black Phoenix +355.52%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.17%
#4 Akedo Akedo +48.78%
#5 Acurast Acurast +29.95%
#6 BasedHype BasedHype +23.54%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.11%
#9 Avantis Avantis +20.16%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +15.50%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings, Inc.

CRXTQ
Rank in Stocks #40849
Clarus Therapeutics Holdings, Inc. is a pharmaceutical enterprise dedicated to... Clarus Therapeutics Holdings, Inc. is a pharmaceutical enterprise dedicated to developing and marketing oral testosterone replacement therapies across the United States. Its primary offering is JATENZO, an oral soft gel formulation of testosterone undecanoate, prescribed for men suffering from hypogonadism. The company has also entered into licensing agreements, including one with HavaH Therapeutics for androgen treatments targeting inflammatory breast disease and specific types of breast cancer. Additionally, Clarus holds an agreement with The Royal Institution for the Advancement of Learning/McGill University to advance and commercialize McGill's exclusive technology, which is designed to address human conditions associated with CoQ10 deficiencies. Founded in 2003, Clarus Therapeutics Holdings, Inc. is headquartered in Northbrook, Illinois. On September 5, 2022, the company, along with an affiliate, voluntarily sought reorganization under Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware.
Share Price
$0.0014
Last synced: 2023-02-28
Market Cap
$72.83K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Clarus Therapeutics Holdings, Inc. (CRXTQ)

Category

Healthcare
Stock price history for Clarus Therapeutics Holdings, Inc. (CRXTQ)
Highest end of day price: $0.00 on 2023-02-01

Lowest end of day price: $0.03 on 2022-09-01
Stock price history of Clarus Therapeutics Holdings, Inc. from 2022 to 2026
Annual Stock Price Performance
Year Performance
2023 -93.65%
2022 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.22K 84.18%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $261.36 49.85%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $250.62 24.40%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $478.35 47.12%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $134.76 62.92%
US